GlassScriptPhysician profile
Wamaitha Sullivan
NPI 1689908220
$2,513.63
in general payments reported to CMS, 2019-2025
24 companies · $453 in 2025
The $453 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $804 · 2022: $943 · 2023: $233 · 2024: $80.71 · 2025: $453.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $767.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $766.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $463.32 | 2021-2025 | Airsupra, Breztri |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $370.39 | 2021-2022 | |
| Novo Nordisk INC | $268.06 | 2022 | |
| Abbvie INC. | $192.24 | 2021-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $143.48 | 2022 | |
| Genentech USA, INC. | $129.18 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $124.80 | 2025 | Zoryve |
| Ultragenyx Pharmaceutical INC. | $111.78 | 2022 | |
| Idorsia Pharmaceuticals US INC | $110.80 | 2023 | Quviviq |
| Scynexis, INC. | $105.20 | 2022 | |
| Alexion Pharmaceuticals, INC. | $87.68 | 2023 | |
| Biogen, INC. | $60.70 | 2021 | |
| Itamar Medical INC | $58.17 | 2024 | Watchpatone |
| Insulet Corporation | $40.29 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $35.86 | 2021-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Indivior INC. | $35.52 | 2021-2022 | |
| Neurelis, INC. | $34.05 | 2023 | Valtoco |
| Merck Sharp & Dohme LLC | $26.70 | 2021 | |
| Esperion Therapeutics, INC. | $24.88 | 2021 | |
| Exact Sciences Corporation | $23.76 | 2025 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $22.54 | 2024 | Aptima |
| Supernus Pharmaceuticals, INC. | $16.44 | 2022 | |
| Avanir Pharmaceuticals, INC. | $15.44 | 2021 | |
| Ironshore Pharmaceuticals INC. | $12.35 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wamaitha Sullivan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.